Low VWF vs. Type 1 VWD: What is the Difference?
At a Glance
The main difference between Low VWF and Type 1 Von Willebrand Disease is the amount of VWF in the blood. Type 1 VWD is diagnosed when levels are below 30 IU/dL, while Low VWF is between 30 and 50 IU/dL. However, treatment is always based on your bleeding symptoms, not just your specific label.
The difference between “Low von Willebrand factor (VWF)” and Type 1 von Willebrand Disease (VWD) primarily comes down to the exact levels of VWF in your blood and how clinical guidelines classify them. According to the 2021 international guidelines, a formal diagnosis of Type 1 VWD is typically given when your VWF levels are extremely low—specifically below 30 IU/dL (International Units per deciliter, a standard measure of concentration in the blood) [1][2]. If your levels fall between 30 and 50 IU/dL, doctors use the category “Low VWF” [1][3]. While people with a formal Type 1 VWD diagnosis are significantly more likely to experience bleeding problems, people in the Low VWF range may or may not have a higher risk of bleeding [3][4].
Understanding the “Low VWF” Category (30-50 IU/dL)
Having Low VWF means your levels are lower than the average person’s, but not quite low enough to meet the strict criteria for a full disease diagnosis [5][2]. In the past, this caused a lot of confusion because many patients in this 30 to 50 IU/dL “gray area” were diagnosed with Type 1 VWD, only to have that diagnosis removed later when guidelines became stricter.
The medical community created the “Low VWF” category to acknowledge that while you don’t have the severe deficiency seen in classic Type 1 VWD, your levels are still low enough that they might cause bleeding issues for you [5][2]. It is also important to know that VWF levels naturally fluctuate with stress, exercise, hormones, and age [2][6]. Because of this, someone with levels in the 30-50 IU/dL range might easily cross over into the “normal” range (above 50 IU/dL) on subsequent tests [6][7].
The Role of Blood Type O
Your blood type plays a major role in how much VWF your body naturally keeps in circulation. People with Type O blood naturally have lower levels of VWF compared to people with blood types A, B, or AB [8][9].
Because of this, VWF levels between 30 and 50 IU/dL in someone with Type O blood might actually represent their normal, healthy baseline rather than a disease state [10][11]. Your body may clear VWF from the bloodstream faster simply because of your blood type’s genetics [12][13]. Doctors must take your blood type into account to distinguish between natural, physiological differences and a true bleeding disorder [10][11].
However, it is crucial to understand: even if your lower levels are considered a “normal baseline” for your blood type, if you are experiencing excessive bleeding, your symptoms are still valid and warrant treatment.
Do You Still Need Treatment?
The most important thing to know is that treatment is based on your bleeding symptoms, not just the name of your diagnosis [5][3]. There is no medical consensus that Low VWF requires an entirely different management plan than mild Type 1 VWD [5][4].
If you have a “Low VWF” label but experience frequent nosebleeds, heavy menstrual periods, or prolonged bleeding after dental work, your doctor can and should treat you [1][14]. Medical professionals use a questionnaire called a Bleeding Assessment Tool (BAT) to score your bleeding history and determine if treatment is necessary [2][7]. This is typically a structured interview that you and your doctor complete together to objectively measure your symptoms [2].
If treatment is needed, the options are the same as those used for mild Type 1 VWD [5]. This might include:
- Hormonal therapies: Such as birth control pills or hormonal IUDs, which are often the first-line treatment for managing heavy menstrual periods [1].
- Desmopressin: A medication that temporarily signals your body to release its stored VWF [15].
- Antifibrinolytics: Medications that prevent blood clots from breaking down too quickly, often useful for dental work or managing heavy periods [15][16].
Regardless of the exact diagnostic label, a proactive plan should be in place before you undergo surgeries, give birth, or have dental procedures [1][14].
Common questions in this guide
What VWF levels indicate Type 1 Von Willebrand Disease versus Low VWF?
Does having Type O blood affect my VWF levels?
Do I need treatment if I am diagnosed with Low VWF instead of Type 1 VWD?
How will my doctor decide if my bleeding symptoms require treatment?
Questions for Your Doctor
5 questions
- •Given my VWF levels, should we complete a standardized Bleeding Assessment Tool (BAT) together to officially score my bleeding history?
- •What is our plan for managing potential bleeding if I need surgery, dental work, or have heavy menstrual periods?
- •If I have heavy periods, would hormonal therapy, antifibrinolytics, or a combination of both be the best approach for me?
- •Should I undergo a trial of desmopressin to see if it safely raises my VWF levels before an emergency or surgery arises?
- •How might my blood type O be influencing my results, and should we recheck my VWF levels to see if they fluctuate over time?
Questions for You
4 questions
- •Have I experienced bleeding symptoms that affect my daily life, such as heavy periods, frequent nosebleeds, or prolonged bleeding after minor cuts or dental work?
- •Is there anyone in my immediate or extended family who has a history of bleeding problems or Von Willebrand Disease?
- •Have my VWF levels been tested more than once, and did factors like stress, illness, or hormonal changes seem to affect the results?
- •Do I have my exact blood type recorded, and was that discussed when interpreting my VWF test results?
References
References (16)
- 1
ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease.
James PD, Connell NT, Ameer B, et al.
Blood advances 2021; (5(1)):280-300 doi:10.1182/bloodadvances.2020003265.
PMID: 33570651 - 2
Effect of age on ISTH-BAT scores and low VWF diagnosis in the Zimmerman Program.
Atiq F, Christopherson PA, Doherty D, et al.
Blood advances 2025; (9(19)):4780-4789 doi:10.1182/bloodadvances.2025016725.
PMID: 40590872 - 3
Management of elective procedures in low von Willebrand factor patients in the LoVIC study.
Doherty D, Lavin M, O'Sullivan JM, et al.
Journal of thrombosis and haemostasis : JTH 2021; (19(3)):701-710 doi:10.1111/jth.15220.
PMID: 33346399 - 4
Bleeding Symptoms and von Willebrand Factor Levels: 30-Year Experience in a Tertiary Care Center.
Moonla C, Akkawat B, Kittikalayawong Y, et al.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2019; (25()):1076029619866916 doi:10.1177/1076029619866916.
PMID: 31359769 - 5
2025 ASH ISTH NBDF WFH monitoring report on the 2021 clinical guidelines on the diagnosis and management of von Willebrand disease.
James PD, Flood VH, Connell NT
Blood advances 2025; (9(14)):3553-3555 doi:10.1182/bloodadvances.2025016512.
PMID: 40273329 - 6
Von Willebrand factor and von Willebrand disease in ageing: mechanisms, evolving phenotypes, and clinical implications.
Seidizadeh O, Atiq F, Connell NT, et al.
The Lancet. Haematology 2025; (12(11)):e908-e917 doi:10.1016/S2352-3026(25)00262-5.
PMID: 41193118 - 7
Longitudinal bleeding assessment in von Willebrand disease utilizing an interim bleeding score.
Lavin M, Christopherson P, Grabell J, et al.
Journal of thrombosis and haemostasis : JTH 2022; (20(10)):2246-2254 doi:10.1111/jth.15807.
PMID: 35780487 - 8
Impact of ABO Blood Group on Bleeding and Clotting Time Among Healthy North Indian Males: A Pilot Study.
Shukla M, Patel S, Janardhana N, Alauddin W
Cureus 2025; (17(12)):e99265 doi:10.7759/cureus.99265.
PMID: 41541987 - 9
Clinical and laboratory presentation of von Willebrand disease: Experience from a single center in Saudi Arabia.
Owaidah T, Alharbi M, Mandourah M, et al.
Journal of Taibah University Medical Sciences 2023; (18(2)):413-419 doi:10.1016/j.jtumed.2022.10.019.
PMID: 37102076 - 10
Knowledge of Blood Group Decreases von Willebrand Factor Panel Testing in Children.
Archer NM, Forbes PW, Brugnara C
HemaSphere 2017; (1(1)):e3 doi:10.1097/HS9.0000000000000003.
PMID: 31723732 - 11
Phenotypic and Genotypic Signatures of VWF Exon 18 in Eastern Saudi Patients Previously Diagnosed with Type 1 von Willebrand Disease.
Alzahrani FM, Al Faris AA, Bashawri LA, et al.
International journal of general medicine 2022; (15()):5385-5394 doi:10.2147/IJGM.S364818.
PMID: 35677804 - 12
Aging and ABO blood type influence von Willebrand factor and factor VIII levels through interrelated mechanisms.
Albánez S, Ogiwara K, Michels A, et al.
Journal of thrombosis and haemostasis : JTH 2016; (14(5)):953-63 doi:10.1111/jth.13294.
PMID: 26875505 - 13
Rise of levels of von Willebrand factor and factor VIII with age: Role of genetic and acquired risk factors.
Biguzzi E, Castelli F, Lijfering WM, et al.
Thrombosis research 2021; (197()):172-178 doi:10.1016/j.thromres.2020.11.016.
PMID: 33221577 - 14
How to manage bleeding disorders in aging patients needing surgery.
Abou-Ismail MY, Connell NT
Hematology. American Society of Hematology. Education Program 2021; (2021(1)):529-535 doi:10.1182/hematology.2021000288.
PMID: 34889441 - 15
von Willebrand disease.
Seidizadeh O, Eikenboom JCJ, Denis CV, et al.
Nature reviews. Disease primers 2024; (10(1)):51 doi:10.1038/s41572-024-00536-8.
PMID: 39054329 - 16
Von Willebrand's Disease.
Mannucci PM, Franchini M
The New England journal of medicine 2017; (376(7)):701 doi:10.1056/NEJMc1616060.
PMID: 28207207
This page is for informational purposes only and does not replace professional medical advice. Always consult your hematologist or healthcare provider to interpret your specific VWF levels and bleeding symptoms.
Get notified when new evidence is published on Von Willebrand Disease.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.